Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2026 09:05 ET | Source: MannKind

MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026

MANNKIND TO PRESENT NEW DATA FROM PEDIATRIC AND ADULT STUDIES OF AFREZZA® AT ATTD 2026
March 05, 2026 16:30 ET | Source: MannKind

MannKind Announces Settlement of Convertible Senior Notes

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the settlement of the remaining $36.3 million aggregate principal...
March 04, 2026 09:00 ET | Source: MannKind

MannKind to Participate in Upcoming Investor Conferences

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today its attendance at two upcoming investor conferences, at...
February 26, 2026 08:00 ET | Source: MannKind

MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Q4 2025 revenues of $112M, +46% vs. Q4 2024 Furoscix® Q4 2025 net sales of $23M, +91% vs. Q4 2024 Afrezza® Q4 2025 net sales of $23M, +25% vs. Q4 2024 2025 full year revenues of $349M, +22% vs....